circle

INVESTORS & MEDIA

PRESS RELEASES

  • Webcast
    X 31st Annual Piper Jaffray Healthcare Conference
    Dec 4, 2019 1:00 PM EST

    31st Annual Piper Jaffray Healthcare Conference
    Dec 4, 2019 1:00 PM EST
Date Title and Summary
Toggle Summary Cytokinetics Announces Vision 2025 and Outlines 2020 Corporate Milestones
Top-line Results from GALACTIC-HF Now Expected in Q4 2020; Commercial Readiness Underway REDWOOD-HCM Initiated; Second Cardiac Myosin Inhibitor Planned to Enter Clinic in 1H 2020 SOUTH SAN FRANCISCO, Calif. , Jan. 13, 2020 (GLOBE NEWSWIRE) -- Cytokinetics, Inc.
Toggle Summary Cytokinetics Announces Start of REDWOOD-HCM, a Phase 2 Clinical Trial of CK-3773274
Next-Generation Cardiac Myosin Inhibitor Advances In Clinical Trial Designed to Assess Effects Using Two-Week Dose Titration Schedule SOUTH SAN FRANCISCO, Calif. , Jan. 06, 2020 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that REDWOOD-HCM ( R andomized E valuation